Osteoporosis Drugs Market - Global Industry Research Report, 2022

Global Osteoporosis Drugs Market (Size
of $8,835.4 million in 2015) to Witness
3.8% CAGR During 2016 – 2022
[email protected]
Global Osteoporosis Drugs Market
The global osteoporosis drugs market is growing at a significant rate due to
growing geriatric population, increasing awareness of osteoporosis and
increasing healthcare expenditure. The increasing prevalence of
osteoporosis in postmenopausal women and the increasing focus on
research & development of new drugs for treatment of osteoporosis are
also driving the growth of the global osteoporosis drugs market.
Explore Full Report at: https://www.psmarketresearch.com/marketanalysis/osteoporosis-drugs-market
Global Osteoporosis Drugs Market
The information and data in the publication “Global Osteoporosis Drugs Market Size, Share,
Development, Growth and Demand Forecast to 2022” represent the research and analysis of
data from various primary and secondary sources. The bottom-top approach has been used
to calculate the global market size by drug class. P&S Market Research analysts and
consultants interacted with authorities from leading companies of the concerned domain to
substantiate every value of data presented in the report. The company bases its primary
research on discussions with prominent professionals and analysts in the industry, which is
followed by informed and detailed online and offline research.
Osteoporosis disease is the most common bone disease, which occurs due to reduced bone
mineral density and causes increased risk of fractures and fragile bones. It leads to
abnormally porous bones such as sponge, which facilitate the weakening of bones and
painful fracture. Most of the spine, hip, shoulder and forearm fractures occur within aged
people of 65 years and above.
Some of the signs and symptoms of the osteoporosis are falling risk and fractures.
Diagnostic tests of osteoporosis include X-Ray test and traditional radiography tests, which
is further confirmed by bone density test. Osteoporosis disease can be managed by
nutrition emphasis, lifestyle management and medicines. The factors such as strict
regulatory requirement for the approval of osteoporosis drugs, patent expiry of blockbuster
drugs, and side-effects and complications associated with osteoporosis drugs are inhibiting
the growth of the global market.
Global Osteoporosis Drugs Market
Geographically, North America dominated the global market of osteoporosis drugs in 2015;
whereas the Asia-Pacific market is expected to witness the fastest growth, a CAGR of 4.2%
during the forecast period. This is due to the growing geriatric population, increasing
awareness of osteoporosis drugs and increasing healthcare expenditure in the region.
Some of the key companies operating in the global osteoporosis drugs market include Eli
Lilly and Company, Pfizer Inc., F. Hoffmann-La Roche, Novartis International AG, Merck & Co.
Inc. and Amgen Inc.
Global Osteoporosis Drugs Market
Download report sample at:
For information regarding permissions and other queries
Kindly write to:
[email protected]
US/Canada Toll-Free: 1-888-778-7886